By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biomedical Advanced Research and Development Authority (BARDA) 

330 C Street, SW
Room G640
Washington  D.C.  20201  U.S.A.
Phone: 202-260-1200 Fax: 202-205-4520



Company News
BARDA Gives Notice Of Intent To Exercise First Contract Option To Further Fund MediWound (MDWD)’s Nexobrid Development 6/23/2017 8:11:24 AM
Cytori (CYTX) And BARDA Execute $13.4 Million Contract Option For Burn Clinical Trial 5/31/2017 8:46:33 AM
Emergent BioSolutions (EBS) To Unveil Its Expanded Center For Innovation In Advanced Development And Manufacturing Supported Through Public-Private Partnership With BARDA 5/9/2017 10:44:58 AM
Cerus (CERS) Announces Exercise Of Additional BARDA Contract Options Totaling $46.6 Million To Support INTERCEPT Red Blood Cell System Development 5/9/2017 9:19:52 AM
Cytori (CYTX) Receives FDA Approval For Burn Clinical Trial Related To BARDA Contract 4/10/2017 10:48:57 AM
ABL Biotechnologies Awarded BARDA Contract To Fill Live Virus-Based Medical Countermeasures 4/5/2017 8:36:56 AM
SRI International Awarded Two BARDA Contracts To Provide Nonclinical Research Services 3/9/2017 9:16:52 AM
BARDA Awards IDT Biologika Contract For Live Virus Filling And Finishing Services 10/24/2016 8:54:52 AM
BARDA Awards $37.6 Million Contract To Sanofi Genzyme (SNY) To Supply Leukine (Sargramostim) For Potential Public Health Emergency 10/7/2016 11:27:58 AM
NewLink Genetics (NLNK) Awarded $25 Million Contract From BARDA A For Investigational Ebola Zaire Vaccine (V920) 10/5/2016 7:50:06 AM